CLINICAL_TRIALS
trial_result
· 2016-03-28
Clinical Trial Update: Study of the Safety and Efficacy of REGN1033 (SAR391786) in Patients With Sarcopenia [Phase 2]
Summary
A Phase 2 study evaluating the safety and efficacy of REGN1033 (SAR391786) in patients with sarcopenia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Regeneron Pharmaceuticals | Conditions: Sarcopenia | Phase 2 | Status: COMPLETED